The novacor left ventricular assist system: Clinical experience from the novacor registry

Journal of Cardiac Surgery

Volumn 16, Issue 4, 2001, Pages 267-271

  Dagenais, F ^a   Portner, P M ^a   Robbins, R C ^a   Oyer, P E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBOLISM; EQUIPMENT DESIGN; FEMALE; FOLLOW UP; HEART ASSIST DEVICE; HEART LEFT VENTRICLE; HEART TRANSPLANTATION; HISTORY OF MEDICINE; HUMAN; IMPLANT; LONG TERM CARE; MALE; META ANALYSIS; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; REGISTER; SAFETY; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; CANADA; DEVICE REMOVAL; EQUIPMENT DESIGN; EQUIPMENT SAFETY; EUROPE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTHESIS IMPLANTATION; REGISTRIES; SURVIVAL ANALYSIS; TIME; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 0035701624     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2001.tb00521.x     Document Type: Article

References (17)

1. First human use of an electrically powered implantable ventricular assist system
2. Reliability model from the in vitro durability tests of the left ventricular assist system
3. Bridge to transplant with the Novacor left ventricular assist system
4. Long-term home discharge support with Novacor LVAS
5. Inflow conduit in implantable left ventricular assist device (LVAD): Influence on outcomes
6. Single-center experience with the thoratec ventricular assist device
7. Clinical experience with 111 thoratec ventricular assist devices
8. One hundred long-term implantable left ventricular assist devices: The Columbia Presbyterian interim experience
9. Quality-of-life outcomes in left ventricular assist system: Inpatients and outpatients
10. Quality of life with an implanted left ventricular assist device
11. Mechanical ventricular assistance: An economical and effective means of treating end-stage heart disease
12. Evolving costs of long-term left ventricular assist device implantation
13. Activation-induced T cell death and immune dysfunction after implantation of left ventricular assist device
14. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices
15. Novacor left ventricular assist system versus HeartMate vented electric left ventricular assist system as a long-term mechanical circulatory support in bridging patients: A prospective study
16. Predictors for weaning patients from ventricular assist devices
17. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure